PASSED A NEW SEARLE'S MEDICINE BY FDA

Celebrex, a new 'revolutionary' medicine against pain and inflammation due to rheumatic and osteo-articular diseases has been approved by the Food and Drug Administration (FDA). The product is the result of the Searle's investigation and will be presented in “co-marketing” by the “G.D.Searle & Co”, that is the pharmaceutical division of the “Monsanto Company” and by the “Pftizer Inc”. The realisation of the Celebrex has been possible thanks to a very advanced molecular technology.